edwards lifesciences corporation | Edwards Lifesciences

Keyword	CPC	PCC	Volume	Score	Length of keyword
edwards lifesciences corporation	1.78	1	1297	100	32
edwards	0.04	0.4	5204	73	7
lifesciences	0.67	0.2	5973	70	12
corporation	1.73	0.3	5951	94	11

Keyword	CPC	PCC	Volume	Score
edwards lifesciences corporation	1.61	0.6	1761	68
edwards lifesciences corporation stock	0.12	0.6	7627	8
edwards lifesciences corporation ew	0.14	1	90	100
edwards lifesciences corporation costa rica	0.26	0.4	6939	20
edwards lifesciences corporation ir	0.22	0.8	5858	16
edwards lifesciences corporation cio	1.46	0.3	340	62
edwards lifesciences corporation logo	1.56	0.1	9861	62
edwards lifesciences corporation news	1.4	1	9255	40
edwards lifesciences corporation email	1.8	0.5	1322	93
edwards lifesciences corporation irvine	0.7	1	109	93
edwards lifesciences corporation careers	0.16	0.4	9933	5
edwards lifesciences corporation address	2	0.6	6179	72
edwards lifesciences corporation locations	1.26	0.8	5925	27
edwards lifesciences corporation irvine ca	1.5	0.8	5320	32
edwards lifesciences corporation stock price	0.45	0.2	9369	56
edwards lifesciences corporation subsidiaries	0.58	0.8	2750	74
edwards lifesciences corporation utah	0.2	0.9	7438	73

Search Results related to edwards lifesciences corporation on Search Engine

Edwards Lifesciences - the leader in heart valves & hemodynamic
edwards.com:443

https://www.edwards.com:443/

WEBInnovation starts with human inspiration. Come to be inspired. United States - English. Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

DA: 22 PA: 32 MOZ Rank: 99

Edwards Lifesciences - Wikipedia
wikipedia.org:443

https://en.wikipedia.org:443/wiki/Edwards_Lifesciences

WEBCardiac surgery technology. Revenue. $5.2 billion (2021) [2] Number of employees. 14,000 (2020 [3]) Website. edwards .com. Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

DA: 96 PA: 57 MOZ Rank: 72

Who We Are | Edwards Lifesciences
edwards.com:443

https://www.edwards.com:443/about-us/who-we-are

WEBEdwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes ...

DA: 16 PA: 28 MOZ Rank: 3

Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
yahoo.com:443

https://finance.yahoo.com:443/news/beat-likely-edwards-lifesciences-ew-150100195.html

WEB1 day ago · Edwards Lifesciences Corporation EW is scheduled to report first-quarter 2024 results on Apr 25, after market close. In the last reported quarter, the company’s adjusted earnings per share of 64 ...

DA: 93 PA: 25 MOZ Rank: 6

Edwards Lifesciences Corp - Overview
edwards.com:443

https://ir.edwards.com:443/overview/default.aspx

WEBEdwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes ...

DA: 52 PA: 87 MOZ Rank: 48

Newsroom | Edwards Lifesciences
edwards.com:443

https://www.edwards.com:443/newsroom

WEBAbout us. Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve ...

DA: 49 PA: 64 MOZ Rank: 74

Edwards Lifesciences Corp - EDWARDS LIFESCIENCES …
edwards.com:443

https://ir.edwards.com:443/news/news-details/2023/EDWARDS-LIFESCIENCES-REPORTS-THIRD-QUARTER-RESULTS/default.aspx

WEBIRVINE, Calif., Oct. 25, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2023. Recent Highlights and Outlook. Q3 sales grew 12 percent to $1.48 billion; constant currency 1 sales grew 11 percent. Q3 TAVR sales grew 11 percent; constant currency sales grew 10 percent.

DA: 24 PA: 97 MOZ Rank: 47

Edwards Lifesciences | LinkedIn
linkedin.com:443

https://www.linkedin.com:443/company/edwards-lifesciences

WEBEdwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery ...

DA: 51 PA: 15 MOZ Rank: 5

Edwards Lifesciences Corp - Edwards’ EVOQUE Valve …
edwards.com:443

https://ir.edwards.com:443/news/news-details/2024/Edwards-EVOQUE-Valve-Replacement-System-First-Transcatheter-Therapy-to-Earn-FDA-Approval-for-Tricuspid-Valve/default.aspx

WEBFeb 02, 2024. Download. IRVINE, Calif.-- (BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

DA: 99 PA: 81 MOZ Rank: 51

Edwards Lifesciences Corp - EDWARDS LIFESCIENCES …
edwards.com:443

https://ir.edwards.com:443/news/news-details/2023/EDWARDS-LIFESCIENCES-OUTLINES-GROWTH-STRATEGY-AT-ANNUAL-INVESTOR-CONFERENCE/default.aspx

WEBIRVINE, Calif., Dec. 7, 2023 – Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s sharpened focus and strategy for longer-term growth, provide an update on its technology pipeline and share financial guidance 1 today …

DA: 89 PA: 89 MOZ Rank: 49